Fulcrum Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell FULC and other ETFs, options, and stocks.

About FULC

Fulcrum Therapeutics, Inc. is a clinical stage biopharmaceutical company, which develops new medicines and focuses on unlocking gene control mechanisms to develop small molecule therapies. Its product candidate includes Losmapimod and FTX-HbF. 

CEO
Alexander C. Sapir
CEOAlexander C. Sapir
Employees
45
Employees45
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2015
Founded2015
Employees
45
Employees45

FULC Key Statistics

Market cap
190.28M
Market cap190.28M
Price-Earnings ratio
-16.19
Price-Earnings ratio-16.19
Dividend yield
—
Dividend yield—
Average volume
333.97K
Average volume333.97K
High today
$3.53
High today$3.53
Low today
$3.39
Low today$3.39
Open price
$3.50
Open price$3.50
Volume
229.03K
Volume229.03K
52 Week high
$10.13
52 Week high$10.13
52 Week low
$2.32
52 Week low$2.32

Analyst ratings

50%

of 6 ratings
Buy
33.3%
Hold
50%
Sell
16.7%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.